Tower Research Capital LLC (Trc) Cytosorbents Corp Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Cytosorbents Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,095 shares of CTSO stock, worth $2,095. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,095
Previous 2,981
29.72%
Holding current value
$2,095
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CTSO
# of Institutions
59Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.09 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$2.78 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.95 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.68 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.25 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $43.6M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...